SIO

The Society of Interventional Oncology serves as the only member-based organization dedicated to the emerging field of IO. (Est 1/17/17)

[SIO @SIO_Central]

Treatment options for advanced melanoma continue to evolve following progression on PD-1 inhibitors. Explore second-line therapies, oncolytic immunotherapies, and multidisciplinary care strategies in this upcoming SIO webinar.
👉 https://t.co/Vdwf74ufcW

[SIO @SIO_Central]

Keep the learning going with #SIOBoneClub!
🦴Oct. 7: Using Neuromonitoring to Avoid Complications in MSK and Pain Procedures
🦴Oct. 28: Foundations of Safety and Effectiveness in MSK and Pain Procedures
Register: https://t.co/Vdwf74ufcW

[SIO @SIO_Central]

4 days left! If your #SIOToronto abstract is still in draft mode, now's the time to hit submit. Abstract submissions close on October 2. Share your research and contribute to the evidence shaping #InterventionalOncology. https://t.co/iFl2UdUoJ4

[SIO @SIO_Central]

Join the Interventional Oncology Working Group at the Alliance Fall 2026 Group Meeting to engage with ongoing clinical research efforts and the future direction of IO trials. @ALLIANCE_org Register: https://t.co/tH147SgiBJ

[SIO @SIO_Central]

Applications for the #SIOToronto RISE Forum Scholarship close Sept. 25. Designed for PhD candidates, medical students, residents, fellows, early-career physicians, and clinician-researchers interested in advancing #InterventionalOncology research. https://t.co/JG7qdNvAkI

[SIO @SIO_Central]

Don’t miss the largest cancer immunotherapy conference! Join #SITC26, the premier event for cancer IO professionals Nov. 4–8 in Phoenix, AZ, or virtually. Connect with top experts and discover the latest breakthroughs in the field. Register today: https://t.co/YqM3MWQ1ha

[SIO @SIO_Central]

Ready to build or expand your breast cryoablation practice? Vijay Ramalingam, MD, FSIR, shares why SIO’s Breast Cryoablation Master Class offers practical, start-to-finish training and valuable connections. Register: https://t.co/nWkMa0dihN

[SIO @SIO_Central]

Join SIO for a webinar exploring second-line treatment strategies, the role of oncolytic immunotherapies and how collaboration between interventional radiology and medical oncology can support the management of metastatic melanoma. @rahulshethmd Register: https://t.co/ob5AwMB8pa

[SIO @SIO_Central]

#HCC treatment decisions are becoming increasingly complex as new evidence emerges. Join SIO's HCC Webinar Series #2 for a multidisciplinary discussion on translating clinical trial data and real-world sequencing strategies into HCC care. https://t.co/ob5AwMB8pa

[SIO @SIO_Central]

"Immunotherapy and the Interventional Oncologist: Challenges and Opportunities — A Society of Interventional Oncology White Paper" reviews the evidence, clinical rationale, and future directions for combining Y-90 and immunotherapy in HCC. Read more: https://t.co/J6N8oyfm7G

[SIO @SIO_Central]

One week left! ⏰ Medical students, residents, fellows and early-career physicians: Apply for the IO Essentials Scholarship for #SIOToronto and receive free registration, travel support, hands-on training and more. Apply by September 18. 👉 https://t.co/z6Sr1w1QQ5

[SIO @SIO_Central]

Registration is now open for #SIOToronto. Join the global #InterventionalOncology community February 24-28, 2027, for the latest research, hands-on learning, and multidisciplinary collaboration. 🔗 https://t.co/7a82IT1sB2

[SIO @SIO_Central]

What’s the right combination for the right patient at the right time?
SIO’s #HCC Webinar Series explores how combination therapy strategies can be tailored across disease stages and treatment settings to support more personalized care. https://t.co/ob5AwMB8pa

[SIO @SIO_Central]

Complication management is a critical part of MSK and pain interventions. Bone Club #1 explores practical strategies for recognizing, preventing, and managing complications through expert-led, case-based discussion. https://t.co/Vdwf74ufcW

[SIO @SIO_Central]

@JohnsHopkins, led by site PIs @MajidKhan_spine and Kristin Redmond, MD, is now enrolling as the eighth site activated in the TRIBUTE Trial, and has enrolled its first patient, advancing research on ablation + palliative radiation for high-risk bone metastases. #TRIBUTEStudy

[SIO @SIO_Central]

SIO is proud to announce @MedicalCollege, led by site PIs @MattScheidtVIR and Ciani Ellison, MD, is the 7th site activated for SIO’s TRIBUTE Trial and has enrolled its first patient, advancing research in ablation + radiation for high-risk bone metastases. #TRIBUTEStudy

[SIO @SIO_Central]

The #SIOToronto RISE Forum Scholarship is now open. Know an early-career investigator or researcher in #IO? Share this opportunity. Scholarship recipients receive travel & housing assistance, complimentary SIO membership, and discounted registration. https://t.co/JG7qdNvAkI

[SIO @SIO_Central]

SIO's fall webinar series tackle key challenges in #InterventionalOncology.
🩺 HCC: combination therapies, treatment sequencing, and multidisciplinary care
🦴 Bone Club: complication management, neuromonitoring, and procedural safety
👉 https://t.co/ob5AwMB8pa

[SIO @SIO_Central]

SIO is proud to partner with the Musculoskeletal Tumor Society (MSTS) for the 2026 MSK Master Class. We're bringing the #IO and #OrthopedicOncology communities together through case-based learning, multidisciplinary discussion, and hands-on training. https://t.co/UxglLeomTH

[SIO @SIO_Central]

The MSK Master Class combines pre-course lectures, case-based discussions, and hands-on lab training to help clinicians build confidence in MSK interventions. 👉 Explore the agenda and register to strengthen your MSK practice: https://t.co/UxglLeomTH